THYROCARE · Health Care · 2026-08-21

Thyrocare Technologies Ltd

6.1★ FairStrong +6.9Stage 2 · wk 11In scan: Pullback Hunter · Prop ScanMARKET: BULL RISING · 2026-08-21
₹565.6
-0.20% today
₹9,001 Cr · Mid cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Visit company website →
P/E (TTM)
50.0
Forward 37.5
Earnings Growth (YoY)
+116.4%
Revenue +19.7%
ROE
+28.7%
Profit margin +19.7%
Dividend Yield
1.86%
P/B 15.2
vs 52W High
-12.9%
₹349.6 lo₹649.4 hi
12.9% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 11
1w13w26w
Week 11 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
20.5%
200 DMA: ₹469.3 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.38x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +5.9% vs MA50 +7.5%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #32 of 84 Stage 2 stocks in Health Care by RS.
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
55.6%
20d Δ
-7.4pp
1M return
-2.8%
3M return
+2.0%
Industry Stage-2 % · last 20 days
Ranks #3 of 15 Stage 2 stocks in this industry. Top tier.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 18w
S2 30w
S2 20w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 10w → S2 10w → S3 5w → S2 18w → S3 5w → S2 4w → S3 4w → S2 30w → S3 6w → S4 9w → S1 4w → S2 20w → S3 3w → S2 11w → S3 7w → S4 8w → S1 3w → S2 11w current
Total tracked: 168 weeks across 18 stage runs.
1M
+3.7%
3M
+21.4%
6M
+39.0%
YTD
+26.0%
1Y
+24.0%
Scan Membership
Pullback Hunter
Latest: 2026-08-21
Prop Scan
Latest: 2026-08-21
60 appearances in last 60 days. First seen: 2026-06-25.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 11 · Vol —x
2026-08-20S2
Wk 11 · Vol —x
2026-08-19S2
Wk 11 · Vol —x
2026-08-18S2
Wk 11 · Vol —x
2026-08-17S2
Wk 11 · Vol —x
2026-08-14S2
Wk 10 · Vol —x
2026-08-13S2
Wk 10 · Vol —x
2026-08-12S2
Wk 10 · Vol —x
2026-08-11S2
Wk 10 · Vol —x
2026-08-10S2
Wk 10 · Vol —x
2026-08-07S2
Wk 9 · Vol —x
2026-08-06S2
Wk 9 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹563.5
200 DMA
₹469.3
52W High
₹649.4
52W Low
₹349.6
5D Low
₹565.6
Resistance levels (recent highs)
20d High
₹649.4
60d High
₹649.4
120d High
₹649.4
250d High
₹649.4
Next resistance
+14.8%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.